Figure 2From: LC-MS/MS analysis of plasma polyunsaturated fatty acids in type 2 diabetic patients after insulin analog initiation therapyLevels of polyunsaturated fatty acids in patients before and after insulin analog therapy. A) AA B) DGLA C) EPA D) DHA. DGLA, Dihomo-gamma-linolenic acid; AA, Arachidonic acid; EPA, Eicosapentaenoic acid; DHA, Docosahexaenoic acid.Back to article page